
NIAID utilizes $577M to establish nine pathogen antiviral drug development centers
Through awards amounting to approximately $577 million, the National Institute of Allergy and Infectious Diseases (NIAID) is working to create nine Antiviral Drug Discovery (AViDD) Centers for... Read More »